1st Edelris Symposium on Affinity Selection-Mass Spectrometry in Drug Discovery

High Throughput Technology for Hit Generation

 Virtual Event    June 2-3

Keynote Speaker

Targeting RNA With Small Molecules Using Affinity-Selection Mass Spectrometry (KL01)

Dr Elliot B. NICKBARG
Dr Elliot B. NICKBARG
MERCK RESEARCH LABORATORIES, Boston, United States
Read more

Plenary Speakers

Accelerating Drug Discovery with the Integration of Affinity Selection Mass Spectrometry (PL02)

Dr Damian HOUDE
Dr Damian HOUDE
RELAY THERAPEUTICS, Cambridge, United States
Read more

Fishing from an Exclusive Pond Using AS-MS (PL03)

Dr Didier ROCHE
Dr Didier ROCHE
EDELRIS, Lyon, France
Read more

Adapting the AS-MS Technology to GPCR Ligand Discovery (PL04)

Prof. Wenqing SHUI
Prof. Wenqing SHUI
SHANGHAITECH UNIVERSITY, Shanghai, China
Read more

MALDI-TOF AS-MS – a Viable Alternative for LC-MS-based Workflows? (PL06)

Dr Roman SIMON
Dr Roman SIMON
BOEHRINGER INGELHEIM PHARMA, Biberach, Germany
Read more

Lessons Learned from Pfizer’s Experience in utilizing Affinity Selection by Mass Spectrometry for Hit Identification (PL05)

Dr Matthew D. TROUTMAN
Dr Matthew D. TROUTMAN
PFIZER, Groton, United States
Read more

Discovery of Bioactive Natural Products Using Affinity Selection-Mass Spectrometry (PL01)

Prof. Richard  VAN BREEMEN
Prof. Richard VAN BREEMEN
OREGON STATE UNIVERSITY, Corvallis, United States
Read more